Cecil Farrington
Family Medicine · Salisbury, NCNPI 1114913134
Payments from drug & device makers
Across 708 payments — averaging $8970.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$4.9M
- AbbVie$601K
- Merck$425K
- GSK$159K
- AstraZeneca$115K
- Regeneron$103K
- plus $60K from 23 others
Across 14 payments — averaging $127.71 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$2K
What the payments were for
- Travel & lodging$90114%
- Food & beverage$5,29885%
- Gifts$200%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 274 | $4,888,567 |
| AbbVie | 57 | $600,817 |
| Merck | 66 | $425,098 |
| GSK | 113 | $158,674 |
| AstraZeneca | 26 | $115,423 |
| Regeneron | 35 | $102,897 |
| Astrazeneca UK Limited | 10 | $39,068 |
| Perrigo Company PLC | 1 | $16,175 |
| Novo Nordisk | 33 | $1,241 |
| Dr.reddy's Laboratories,inc. | 1 | $1,000 |
| Johnson & Johnson | 13 | $486 |
| Lilly USA, LLC | 18 | $377 |
| Boehringer Ingelheim | 9 | $337 |
| Sanofi-aventis U.S. LLC | 8 | $190 |
| Amgen | 8 | $160 |
| Novartis | 12 | $142 |
| Biohaven Pharmaceuticals, Inc. | 1 | $79 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $75 |
| Bayer | 5 | $75 |
| Abbott | 4 | $74 |
| E.r. Squibb & Sons, L.L.C. | 2 | $27 |
| Hologic Sales And Service, LLC | 1 | $26 |
| Ironwood Pharmaceuticals, Inc | 1 | $23 |
| Si-bone, Inc. | 1 | $21 |
| Lundbeck LLC | 1 | $21 |
| Idorsia Pharmaceuticals US Inc | 1 | $18 |
| Mylan Pharmaceuticals Inc. | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GARDASIL 9$773
- FARXIGA$132
- BREZTRI$125
- RYBELSUS$104
How this compares
$6,351,135 in reported general payments places this provider in the 95th percentile of 3,444 family medicine providers in North Carolina.
Other family medicine in Salisbury
- Kishan MaramrajSalisbury$2.6M
- Barton WilliamsWilmington$17.3M
- Alexander MurrayGreensboro$13M
- Arin PiramzadianJacksonville$13M
- Jonathan WilsonHickory$12.7M
- George RaadCharlotte$7.7M
- Christian MartinShelby$5.4M
- John EarlHickory$4.7M
- Patrick MorganteHavelock$4.6M
- Stephen JonesShelby$4.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.